medline.ch Onkologie Urologische Tumoren

	Cell surface oncofetal antigens in prostate cancer: therapeutic potential and radioligand targeting. EJNMMI Res Harbi E, Bilgin GB, Emmett L, Kendi AT, Orme JJ, Muniz M, Childs DS, Lucien F, Chaudhuri AA, Sartor O. PMID: 41832388 [PubMed - as supplied by publisher]
	Genomic landscape and precision therapy in prostate cancer: current status and future directions. NPJ Precis Oncol Ligon JA, Anand S, Singh S, Siddiqui JA, Henegan JC, Singh AP. PMID: 41832316 [PubMed - as supplied by publisher]
	Predicting aggressiveness of clear cell renal cell carcinoma via mri using artificial intelligence: implications for surgical planning in a retrospective multicenter study. Sci Rep Zhao J, Wang H, Liao R, Liu M, Cui Z, Jin B, Wang Y, Tang R. PMID: 41832286 [PubMed - as supplied by publisher]
	Refining prognostication in non-muscle-invasive bladder cancer: From clinical models to artificial intelligence. Urol Oncol Mardelli C, Bertail T, Tachibana I, Verhoest G, Mathieu R, Pradere B, Xylinas E, Roupret M, Margulis V, Bensalah K, Lotan Y, Khene ZE. PMID: 41832109 [PubMed - as supplied by publisher]
	Clinical utility of large language models in metastatic prostate cancer: A multicenter expert validation for decision support. Eur J Cancer Chen Y, He K, Qu W, Ma L, Su X, Liu X, Kang Z, Li F, Yan J, Wang Z, Li J, Li Z. PMID: 41831267 [PubMed - as supplied by publisher]
	Role of molecular testing in diagnosis of renal neoplasms. Semin Diagn Pathol Gilpatrick T, Sanchez NG, Greenland NY, Sirohi D. PMID: 41831250 [PubMed - as supplied by publisher]
	The prevalence and predictors of previous prostate cancer screening among men attending primary healthcare centers in Riyadh, Saudi Arabia. Ann Med Alshahrani S, Shubair MM, Alfallaj AA, Al-Khateeb BF, Alshahrani A, Almutairi N, Alnaim L, Angawi K, Alharthy A, Othman F, El-Metwally A. PMID: 41830420 [PubMed - indexed for MEDLINE]
	ERG expression in BPH vs prostatic adenocarcinoma and its correlation with Gleason grade group. J Pak Med Assoc Qayyum M, Shawana S, Nomani BH, Khaliq E, Jamal N, Qayyum H. PMID: 41830348 [PubMed - indexed for MEDLINE]
	Serum Chemokines CCL3 and CCL7 as Complementary Diagnostic Biomarkers Across Tumor Grades in Clear Cell Renal Cell Carcinoma. Int J Mol Sci Sokólska W, Zajkowska M, Kulczy, Werel T, Orywal K. PMID: 41828706 [PubMed - indexed for MEDLINE]
	Impact of Heterogeneous DNA Methylation on the Accuracy of Quantitative Methylation-Specific PCR for Detecting DNA Hypermethylation in Prostate Cancer. Int J Mol Sci Visser WCH, de Jong H, Janssen LB, Shrivastava J, Mulders PFA, Schalken JA, Melchers WJG. PMID: 41828470 [PubMed - indexed for MEDLINE]
	Use of Artificial Intelligence Model Associated with Masson's Trichrome Staining as a Predictor of Muscle Invasion in Bladder Cancer. Int J Mol Sci Parrao D, Gallegos H, Ruz K, Lay R, Saavedra C, Guerrero R, Larrañaga M, Lindsay CB, Bravo JC. PMID: 41828460 [PubMed - indexed for MEDLINE]
	Updates on Clinical Trials and Molecular Characteristics of Locally Advanced and Oligometastatic Renal Cell Carcinoma. Int J Mol Sci Ogunmola TM, Jin Z, Kleberg J, Tithi TI, Anvar S, Maharjan CK, Chatzkel JA, Falzarano SM, Kolb R, Kim MC, Zhang W. PMID: 41828416 [PubMed - indexed for MEDLINE]
	Clinical Utility of PROSTest: A Prospective Study Suggesting Reduction in Unnecessary MRI and Biopsy in Men Evaluated for Prostate Cancer. Cancers (Basel) Rahbar K, Bögemann M, Papavasilis P, Halim A, Kidd M. PMID: 41827804 [PubMed]
	Reirradiation of Local Recurrences of Prostate Cancer: PROSTARE (PROstate Cancer STereotActic REirradiation) Early Safety Analysis of a Phase 2 Study with a Limited Cohort. Cancers (Basel) Majewski W, Napieralska A, Miszczyk M, Misiorowska-Go, Krzempek M, St, Rembak-Szynkiewicz J, Wydma. PMID: 41827781 [PubMed]
	mpMRI-Based Risk Estimation to Optimize Prostate Cancer Patient Selection for Active Surveillance. Cancers (Basel) Wallaengen V, Zacharaki EI, Alhusseini M, Breto AL, Kimbel IM, Soodana-Prakash N, Algohary A, Lowry N, Xu IRL, Freitas PF, Gaston SM, Castillo Acosta RP, Kryvenko ON, Ritch CR, Nahar B, Gonzalgo ML, Parekh DJ, Pollack A, Punnen S, Stoyanova R. PMID: 41827775 [PubMed]
	Laser Energy Application in Endoscopic Kidney-Sparing Surgery for Upper Tract Urothelial Carcinoma: A Systematic Review of Oncological Outcomes and Surgical Complications. Cancers (Basel) Zorzi F, Scilipoti P, Moretto S, Gonzalez-Gonzalez C, Nannola N, Robesti D, Folcia A, Chicaud M, Kutchukian S, Candela L, Laurent B, Ventimiglia E, Montorsi F, Briganti A, Salonia A, Villa L, Doizi S, Traxer O, Panthier F. PMID: 41827753 [PubMed]
	VEGF-TKI Outcomes in Metastatic Renal Cell Carcinoma According to Prior Immune Checkpoint Inhibitor or VEGF-TKI: A Scoping Review and Exploratory Analysis. Cancers (Basel) Nally E, Jovaisaite A, Coca Membribes S, Priyadarshini G, Graham C, MacDonald A, Jackson-Spence F, Szabados B, Powles T. PMID: 41827741 [PubMed]
	Liquid Biopsy in Non-Metastatic Prostate Cancer: Clinical Evidence and Future Directions. Cancers (Basel) Sighinolfi MC, Pallotta G, Del Re M, Moosavi K, Schubert O, Rossi F, Gavi F, Assumma S, Panio E, Totaro A, Turri F, Ragonese M, Foschi N, Russo P, Patel E, Gandi C, Palermo G, Scarciglia E, Pinto F, Presutti S, Moschovas MC, Minucci A, Iacovelli R, Ciccarese C, Tagliaferri L, Pierconti F, Nero C, Zannoni GF, Rocco B. PMID: 41827734 [PubMed]
	Bioactive Natural Products Targeting Androgen Receptor Signaling in Prostate Cancer: A Systematic Review. Cancers (Basel) Pratama F, Novitasari D, Mardianingrum R, Holik HA, Ikram NKK, Muchtaridi M. PMID: 41827723 [PubMed]
	Radiomics-Based Characterization of Aggressive Prostate Cancer Variants: Diagnostic Challenges and Opportunities. Cancers (Basel) Sklinda K, Rajca M, Kasprowicz M, Micha, Ma, Olczak B, Walecki J. PMID: 41827718 [PubMed]

Artikel 1 - 20 / 176817

Seite 1 von 8841

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung